BioSpace News Archive

Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, announced today that it has received EUR 1.2 million in funding from the European Fund for Regional Development (EFRO) through the Northern Netherlands Alliance (SNN) and the city and province of Groningen, to support clinical validation of its Liver and Pancreas Sealant Patch.

Today, the U.S. Food and Drug Administration issued warning letters to two breast implant manufacturers for failure to comply with various regulatory requirements.

Doctors and researchers from across Northwell Health’s New York-based hospitals saw an “alarming number” of hospitalized coronavirus disease 2019 patients develop acute kidney injury during the height of the pandemic – rates higher than reported from China, according to new data published in Kidney International, the official journal of the International Society of Nephrology.

Over 90% of target enrollment achieved to date in Phase 2 exploratory study of NYX-783 in PTSD; data readout expected in late 2020

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, announced that it will report its first quarter 2020 financial and operating results after the close of U.S. financial markets on Thursday, May 21, 2020.

Covetrus, a global leader in animal-health technology and services, announced financial results for the first quarter of 2020, which ended March 31, 2020.

Venus Concept Inc., a global medical aesthetic technology leader, announced financial results for the three months ended March 31, 2020.

Seclidemstat Advances Dose Escalation in Phase 1/2 Ewing Sarcoma Clinical Trial; On Track to Report Early Data in 2020

TG Therapeutics, Inc., a biopharmaceutical company dedicated to developing medicines for patients with B-cell mediated diseases, announced that it intends to offer and sell 6,000,000 shares of its common stock in an underwritten public offering.

Company reports robust sales of COVID-19 tests as Co-Diagnostics generates net profit through middle of second quarter